The field of DNA microarray data analysis is getting increasingly complicated as scientists develop new array technologies and analysis algorithms, yet accurate introductory information on the subject ...

Oligonucleotide microarray (DNA chip)–based hybridization analysis is a promising new technology which potentially allows rapid and cost–effective screens for all possible mutations and sequence ...

Experts say growing awareness about the difference between screening and diagnostic tests can help families make informed ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

There was a time when pregnancy tests did not merely announce impending parenthood. They opened the door to nine months of ...

A coronavirus vaccine built to stay useful even as viruses change has cleared its first test in people, offering an early ...

For decades, the accepted explanation for the origins of the Japanese people was relatively straightforward. Modern Japanese ...

Explore how researchers are using next-generation CRISPR therapies to target the root cause of muscle degeneration.

Albert Luderer assumed the role of Interim CEO, with Erik [last name not specified] remaining as an advisor to ensure ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

In this week’s Tech Tuesday, our partners at UF Innovate and SCAD Media highlight Synvitta Diagnostics, a biotech company ...

PM ETSAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, ...